Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant
Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant
复制标题
TLR激动剂作为内置佐剂的全合成碳水化合物疫苗的最新进展
DOI:
10.1016/j.cclet.2017.09.047
复制
发表时间:
2018
影响因子:
9.1
通讯作者:
Zhimeng Wu
中科院分区:
文献类型:
--
作者:
Zhifang Zhou;Han Lin;chen Li;Zhimeng Wu
Fully synthetic vaccine, in which one or multi-molecular antigens are conjugated to a synthetic carrier with well-defined chemical structure, is a new direction to develop carbohydrate-based vaccine against cancer and pathogens. Toll like receptor (TLR) agonists with the ability to stimulate immune response have been widely investigated and been applied as build-in adjuvants to construct fully synthetic vaccines. In particular, remarkable progress has been achieved in recent years in the development of vaccines constructed with the agonists of TLR1/2, TLR2/6 and TLR4 and tumor-associated carbohydrate antigens (TACAs). These di-, tri- or multi-component vaccine candidates showed attractive immunological properties. This review highlights recent advances in developing full synthetic carbohydrate antigen based vaccines, with an emphasis on the structure-activity relationships that provide a primary basis for future vaccine design and immunotherapy developing.
登录
查看更多内容
影响因子:
7.8
作者:
Guo, Zhongwu;Wang, Qianli
通讯作者:
Wang, Qianli
影响因子:
--
作者:
Brendan L Wilkinson;Stephanie L Day;R. Chapman;S. Perrier;V. Apostolopoulos;R. Payne
通讯作者:
Brendan L Wilkinson;Stephanie L Day;R. Chapman;S. Perrier;V. Apostolopoulos;R. Payne
影响因子:
4.9
作者:
Brendan L Wilkinson;L. Malins;Candy K. Y. Chun;R. Payne
通讯作者:
Brendan L Wilkinson;L. Malins;Candy K. Y. Chun;R. Payne
影响因子:
5.5
作者:
Daftarian, P;Sharan, R;Diamond, DJ
通讯作者:
Diamond, DJ
影响因子:
4.3
作者:
Cai, Hui;Huang, Zhi-Hua;Li, Yan-Mei
通讯作者:
Li, Yan-Mei